FDA Inspection
Bristol-Myers Squibb CompanyBristol-Myers Squibb Company – FDA Inspection, Mar 7, 2019
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Company, with an inspection on March 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1606df9f-3d06-4da9-abc7-ec6d0c5879d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1083235
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(d)Failure to submit scientific article
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bristol-Myers Squibb Company
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 7, 2018 | Not classified | New Jersey District Office | |
| April 27, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 2, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 20, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bristol-Myers Squibb Company
- FDA Inspection 1236867 - 2024-04-24
- FDA Inspection 1066837 - 2018-09-07
- FDA Inspection 972194 - 2016-04-27
- FDA Inspection 829516 - 2013-05-02
- FDA Inspection 603837 - 2009-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.